Limbic encephalitis.
Brain MRI
Hippocampal sclerosis
Immunotherapy
Limbic encephalitis
Mediotemporal lobe
Neural autoantibodies
Journal
Handbook of clinical neurology
ISSN: 0072-9752
Titre abrégé: Handb Clin Neurol
Pays: Netherlands
ID NLM: 0166161
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
14
8
2022
pubmed:
15
8
2022
medline:
17
8
2022
Statut:
ppublish
Résumé
Limbic encephalitis (LE) is a clinical syndrome defined by subacutely evolving limbic signs and symptoms with structural and functional evidence of mediotemporal damage in the absence of a better explanation than an autoimmune (or paraneoplastic) cause. There are features common to all forms of LE. In recent years, antibody(ab)-defined subtypes have been established. They are distinct regarding underlying pathophysiologic processes, clinical and magnetic resonance imaging courses, cerebrospinal fluid signatures, treatment responsivity, and likelihood of a chronic course. With immunotherapy, LE with abs against surface antigens has a better outcome than LE with abs to intracellular antigens. Diagnostic and treatment challenges are, on the one hand, to avoid overlooking and undertreatment and, on the other hand, to avoid overdiagnoses and overtreatment. LE can be conceptualized as a model disease for the consequences of new onset mediotemporal damage by different mechanisms in adult life. It may be studied as an example of mediotemporal epileptogenesis.
Identifiants
pubmed: 35964988
pii: B978-0-12-823493-8.00024-9
doi: 10.1016/B978-0-12-823493-8.00024-9
pii:
doi:
Substances chimiques
Autoantibodies
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
467-487Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.